| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.57B | — | +6.4% |
| R&D Expense | $38.0M | — | +2.7% |
| SG&A Expense | $510.0M | — | +9.9% |
| Operating Income | $539.0M | — | +31.1% |
| Interest Expense | $58.0M | — | +1.8% |
| Pre-tax Income | $480.0M | — | +31.1% |
| Income Tax | $127.0M | — | +15.5% |
| Net Income | $340.0M | — | +39.9% |
| EPS (Basic) | $0.88 | — | +44.3% |
| EPS (Diluted) | $0.87 | — | +42.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $834.0M | -23.9% | -56.5% |
| Accounts Receivable | $3.92B | +6.3% | +9.8% |
| Inventory | $669.0M | +9.1% | +14.2% |
| Current Assets | $6.46B | -0.6% | -13.1% |
| Total Assets | $10.54B | -1.0% | -5.7% |
| Current Liabilities | $7.72B | +0.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $413.0M | — | +117.4% |
| Investing Cash Flow | $15.0M | — | +109.3% |
| Financing Cash Flow | -$694.0M | — | -62.1% |
| -2.1% |
| Long-term Debt | $7.57B | -2.2% | -9.5% |
| Total Liabilities | $15.98B | +0.3% | -1.2% |
| Stockholders' Equity | -$5.68B | -5.3% | -10.8% |